Clinical Case Series of Gastrointestinal Symptoms in Patients With Novel Coronavirus ۲۰۱۹ Infection
محل انتشار: مجله تحقیقات دارویی و بیومدیک، دوره: 7، شماره: 2
سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 94
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_PBRE-7-2_008
تاریخ نمایه سازی: 10 دی 1402
چکیده مقاله:
Background: Various digestive symptoms have been frequently reported in a significant portion of patients infected with the virus since the outbreak of Coronavirus Disease ۲۰۱۹ (COVID-۱۹). Most patients with COVID-۱۹ have a fever accompanied by respiratory signs and symptoms, such as cough and dyspnea. We present ۳۶ cases with a chief complaint of Gastrointestinal (GI) symptoms along with respiratory symptoms. In this study, we aimed at investigating the prevalence and outcomes of COVID-۱۹ patients with digestive symptoms.
Methods: A variety of observed GI symptoms included nausea and vomiting (۷۲.۲%), diarrhea (۲۵%), abdominal pain (۱۹.۴%), loss of appetite (۱۴%), and anosmia (۱۴%). The most non-GI symptoms were dyspnea (۶۶.۷%), fever (۶۶.۷%), dry cough (۵۸.۳%), myalgia (۵۲.۴%), and others. Six patients (۱۶.۶%) were critically ill, ۷ (۱۹.۴%) were in stable condition, and ۲۳ patients (۶۴%) showed moderate symptoms. Among the patients, ۷ (۱۹.۵%) needed critical care and were admitted to ICU. Leucopenia, lymphopenia, and elevated acute-phase proteins were other features observed in these patients. The most common antiviral regimen was hydroxychloroquine and oseltamivir. Finally, ۳۲ patients (۸۹%) were discharged, and ۴ (۱۱%) died.
Conclusion: This case series study highlights that patients with COVID-۱۹ are prone to GI symptoms along with fever and respiratory symptoms. Patients may even present with digestive symptoms and without any respiratory symptoms. Hence, clinicians should pay more attention to these patients and help diagnose COVID-۱۹ earlier to start prompt treatment before the occurrence of severe disease.
کلیدواژه ها:
نویسندگان
Hamideh Abbaspour Kasgari
Department of Clinical Pharmacy, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Amir Mohammad Shabani
Department of Clinical Pharmacy, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Hafez Fakheri
Department of Internal Medicine, Gut and Liver Research Center, School of Medicine, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Parnian Mohammadzadeh
Department of Clinical Pharmacy, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :